Cytotoxicity and DNA damage in the neutrophils of patients with sickle cell anaemia treated with hydroxyurea
Hydroxyurea (HU) is the most important advance in the treatment of sickle cell anaemia (SCA) for preventing complications and improving quality of life for patients. However, some aspects of treatment with HU remain unclear, including their effect on and potential toxicity to other blood cells such...
Saved in:
Main Authors: | Alano Martins Pedrosa (Author), Maritza Cavalcante Barbosa (Author), Thayna Nogueira dos Santos (Author), Luzia Kalyne Almeida Moreira Leal (Author), Amanda de Araújo Lopes (Author), Darcielle Bruna Dias Elias (Author), Greyce Luri Sasahara (Author), Bruno Coêlho Cavalcanti (Author), Romélia Pinheiro Gonçalves (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2014-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hydroxyurea for sickle-cell anaemia in Africa: mind the gap
by: Stephen K Obaro
Published: (2015) -
Standardization method for measurement of hydroxyurea by Ultra High Efficiency Liquid Chromatography in plasma of patients with sickle cell disease
by: Darcielle Bruna Dias Elias, et al.
Published: (2014) -
Methemoglobin measure in adult patients with sickle-cell anemia: influence of hydroxyurea therapy
by: Marilia Rocha Laurentino, et al.
Published: (2014) -
Hydroxyurea Pharmacokinetic Evaluation in Patients with Sickle Cell Disease
by: Daniela Di Grazia, et al.
Published: (2024) -
Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
by: Akancha Pandey, et al.
Published: (2022)